A pilot study to investigate the impact of a new pharmacy service on new medicine adherence

Not Applicable

Completed

• Conditions: Medicine adherence; Public Health - Health service research

• Registration Number: ACTRN12617000332325
• Lead Sponsor: PS MedicineWise

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-03
• Study Completion: 2018-12-31
• Last Update Posted: 28 October 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 847

Inclusion Criteria

To be included in the study patients must meet the following criteria:
* Be aged 18 years or above;
* Be a Medicare and/or Department of Veterans affairs (DVA) card holder;
* Be living at home in a community setting;
* Be on a newly prescribed medicine for one of the following conditions:
–Asthma and other lung conditions such as COPD
–Conditions requiring antiplatelet / anticoagulant therapy
–Depression
–Dyslipidaemia
–Hypertension
–Type 2 diabetes
* Be able to understand and willing to consent to the study.

Exclusion Criteria

-Patient cannot communicate sufficiently in English.
-Patients of public or private hospitals, day hospital facilities, transitional care facilities or to residents of an Aged Care facility.
- Patients who are collecting medicine where the only change from the previous medicine involves a dosage, strength, brand or formulation change(s).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome of the study is patient adherence to their newly prescribed medicine at 2, 3 and 6 months following study registration. <br><br>This is assessed using the validated Morisky Medication Adherence Scale, pharmacy dispensing data and PBS data.[2, 3 and 6 months.]

Secondary Outcome Measures

Name	Time	Method
Proportion of patients referred back to their GP.[2 - 4 weeks]